Three ALCL lines carrying the NPM–ALK fusion (Karpas 299, SUDHL-1 and Cost) and one ALK-negative ALCL (FEPD) were incubated with increasing doses of P36 for 48 h. The gene discussed is ALK; the disease is anaplastic large cell lymphoma.